 |
|

|
 |
| While the business is currently experiencing tremendous growth for this US-based medical device company, it is concerned about preserving its long-term profitability which could be impacted by: |
 |
Lopsided revenue distribution: most of the revenues from US and western Europe; less than 15% comes from Asia and less than 5% comes from China, India and other developing nations |
 |
Mounting pressures on profits: with aging population and increasing healthcare costs, all segments of the health industry are anticipating increased pressure on their margins |
 |
Reduce product costs: 95% of their current supply base is located in North America or other expensive labor areas, while other parts of the world offer qualified suppliers with lower cost |
 |
Develop new products: to meet new customer demands for all parts of the world at much lower price points requires new products, requires cheaper ways to develop & manufacture new product |
|
 |
 |
|
We are assisting our client in evaluating their options of sourcing from India and China by: |
 |
Running RFQs for multiple groups of parts, to select a set of qualified suppliers |
 |
Being their US-based supplier for Asian supplied parts by managing orders and payments |
 |
Arranged and accompanied client to India and China for vendor site visits and vendor audits |
|
 |
 |
| Based on the early results, client expects to achieve over 30-50% cost reduction without any significant impact on their inventories or product lead times. They plan to increase their low-cost country sourcing from currently less than 1% of parts to about 10% of their parts |
 |
Source precision machined stainless steel parts from Asia to US that arrive in 5 day lead times |
 |
Using Indian engineers to rationalize their diverse product designs across multiple business, using modular design principles |
|
|